Los puntos clave no están disponibles para este artículo en este momento.
Using a combination of biomarkers may be a feasible strategy to improve the diagnosis of cardioembolic stroke in the acute phase, thus rapidly guiding other diagnostic tests and accelerating the start of optimal secondary prevention.
Montaner et al. (Fri,) studied this question.